Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 22, 2024Open Access

Real-World Effectiveness of First-Line Azacitidine or Decitabine with or without Venetoclax in AML Patients Unfit for Intensive Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

FAFabian AckerGoethe University FrankfurtJCJörg ChromikGoethe University FrankfurtETEmily TiedjenUniversitätsklinikum Gießen und Marburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Acker et al. (2024) studied this question.

synapsesocial.com/papers/68e781eeb6db6435876f4c61https://doi.org/10.21203/rs.3.rs-3945651/v1
View Full Paper
Ask AI
Bookmark
Share